CLASS II Drug recall · Reported 11 Aug 2021 · FDA Enforcement Report
Succinylcholine Chloride 100 mg/ (20 mg/mL) Syringes recalled
BayCare Integrated Service Center, LLC / is recalling Succinylcholine Chloride 100 mg/ (20 mg/mL) Syringes, distributed in Florida. The recall was initiated on 30 Jul 2021 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0702-2021
- FDA event ID
- 88394
- Recalling firm
- BayCare Integrated Service Center, LLC /, Temple Terrace, FL
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 30 Jul 2021
- FDA classified
- 4 Aug 2021
- Reported
- 11 Aug 2021
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Sterility
Timeline
| 30 Jul 2021 | Recall initiated by company | |
| 4 Aug 2021 | Classified by FDA | +5 days |
| 11 Aug 2021 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of sterility assurance
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Succinylcholine Chloride 100 mg/5 mL (20 mg/mL), 5 mL Syringes, Rx only, For IV Use only, BayCare Central Pharmacy, 7802 E. Telecom Parkway, Temple Terrace, FL 33837
Where it was distributed
FL
Questions about this recall
Why was it recalled?
Lack of sterility assurance
Which lots are affected?
Lot: SUCC10020210624 Exp. 09/22/2021
Where was it sold?
FL
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from BayCare Integrated Service Center, LLC /
All 3| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Iohexol (300 mg Iodine/mL) Iodine/, Total Volume in syringe recalled | BayCare Integrated Service Center, LLC / | Labeling Errors | FL |
| Drug | CLASS III | Norepinephrine bitartrate 16 mg in NaCl recalled | BayCare Integrated Service Center, LLC / | Potency & Assay | FL |
Other Succinylcholine Chloride recalls
All 21| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Succinylcholine Chloride Injection, USP 200 mg/ (20 mg/mL) recalledSuccinylcholine Chloride | Zydus Pharmaceuticals | Potency & Assay | 4 states |
| Drug | CLASS II | SUCcinylcholine Chloride 200 mg/ Injection recalled | SCA Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | SUCcinylcholine Chloride 100 mg/ Injection recalled | SCA Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | SUCCINYLcholine Chloride 200 mg/ (20 mg/mL) BD Syringe recalled | New England Life Care | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Succinylcholine Chloride Injection, USP, 200 mg recalled | Accord Healthcare | Manufacturing (CGMP) Deviations | PR |